Published in Chembiochem on July 20, 2009
Multivalent glycoconjugates as anti-pathogenic agents. Chem Soc Rev (2012) 1.41
Glycotherapy: new advances inspire a reemergence of glycans in medicine. Chem Biol (2013) 1.04
Virus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infection. Nat Commun (2012) 0.94
Glycan encapsulated gold nanoparticles selectively inhibit shiga toxins 1 and 2. Bioconjug Chem (2010) 0.87
Glyconanomaterials: Emerging applications in biomedical research. Nano Res (2014) 0.86
Recent advances in engineering polyvalent biological interactions. Biomacromolecules (2014) 0.86
Glycosaminoglycans are interactants of Langerin: comparison with gp120 highlights an unexpected calcium-independent binding mode. PLoS One (2012) 0.84
A review of nanotechnological approaches for the prophylaxis of HIV/AIDS. Biomaterials (2013) 0.83
Nanoparticle-based drug delivery to the vagina: a review. J Control Release (2014) 0.83
Glycosystems in nanotechnology: Gold glyconanoparticles as carrier for anti-HIV prodrugs. Beilstein J Org Chem (2014) 0.81
A general glycomimetic strategy yields non-carbohydrate inhibitors of DC-SIGN. Chem Commun (Camb) (2010) 0.81
Quinoxalinone Inhibitors of the Lectin DC-SIGN. Chem Sci (2011) 0.80
Lectin-carbohydrate interactions on nanoporous gold monoliths. New J Chem (2013) 0.78
Influence of ligand presentation density on the molecular recognition of mannose-functionalised glyconanoparticles by bacterial lectin BC2L-A. Glycoconj J (2013) 0.76
Hydroxytyrosol: a new class of microbicide displaying broad anti-HIV-1 activity. AIDS (2016) 0.75
Linear biocompatible glyco-polyamidoamines as dual action mode virus infection inhibitors with potential as broad-spectrum microbicides for sexually transmitted diseases. Sci Rep (2016) 0.75
Myeloid C-Type Lectin Receptors in Viral Recognition and Antiviral Immunity. Viruses (2017) 0.75
Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nat Rev Microbiol (2009) 2.47
Optimal use of maraviroc in clinical practice. AIDS (2008) 1.60
Immune activation promotes evolutionary conservation of T-cell epitopes in HIV-1. PLoS Biol (2013) 1.44
Glyconanoparticles: types, synthesis and applications in glycoscience, biomedicine and material science. Biochim Biophys Acta (2005) 1.42
Multivalent glycoconjugates as anti-pathogenic agents. Chem Soc Rev (2012) 1.41
TRAF family proteins link PKR with NF-kappa B activation. Mol Cell Biol (2004) 1.40
Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection. J Infect Dis (2005) 1.32
Gold glyconanoparticles as new tools in antiadhesive therapy. Chembiochem (2004) 1.25
Gold Glyconanoparticles as Water-Soluble Polyvalent Models To Study Carbohydrate Interactions This work was supported by the DGICYT (PB96-0820), J.M.F. thanks the MEC for a predoctoral fellowship. A.G.B. thanks CSIC for financial support. We thank Prof. Martín-Lomas for his scientific and financial support. Angew Chem Int Ed Engl (2001) 1.21
Genotypic determination of HIV tropism - clinical and methodological recommendations to guide the therapeutic use of CCR5 antagonists. AIDS Rev (2010) 1.16
A therapeutic dendritic cell-based vaccine for HIV-1 infection. J Infect Dis (2011) 1.15
Gold glyconanoparticles: synthetic polyvalent ligands mimicking glycocalyx-like surfaces as tools for glycobiological studies. Chemistry (2003) 1.14
Glyconanoparticles as multifunctional and multimodal carbohydrate systems. Chem Soc Rev (2013) 1.13
Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression. J Infect Dis (2002) 1.11
Functional characterization of SDF-1 proximal promoter. J Mol Biol (2005) 1.08
Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines. Carbohydr Res (2006) 1.06
Prostratin induces HIV activation and downregulates HIV receptors in peripheral blood lymphocytes. Antivir Ther (2004) 1.05
Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. Proteomics (2006) 1.03
Nanostructured disposable impedimetric sensors as tools for specific biomolecular interactions: sensitive recognition of concanavalin A. Anal Chem (2011) 1.01
SJ23B, a jatrophane diterpene activates classical PKCs and displays strong activity against HIV in vitro. Biochem Pharmacol (2008) 0.99
Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN. Chemistry (2009) 0.98
Thermodynamic evidence for Ca2+-mediated self-aggregation of Lewis X gold glyconanoparticles. A model for cell adhesion via carbohydrate-carbohydrate interaction. J Am Chem Soc (2005) 0.97
Update on clinical and methodological recommendations for genotypic determination of HIV tropism to guide the usage of CCR5 antagonists. AIDS Rev (2012) 0.97
Caspase-3-mediated cleavage of p65/RelA results in a carboxy-terminal fragment that inhibits IkappaBalpha and enhances HIV-1 replication in human T lymphocytes. Retrovirology (2008) 0.96
Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides. Bioconjug Chem (2012) 0.95
CXCL12 gene expression is upregulated by hypoxia and growth arrest but not by inflammatory cytokines in rheumatoid synovial fibroblasts. Cytokine (2010) 0.94
Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12. J Mol Biol (2011) 0.94
Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine. Nanomedicine (Lond) (2012) 0.93
A model system mimicking glycosphingolipid clusters to quantify carbohydrate self-interactions by surface plasmon resonance. Angew Chem Int Ed Engl (2002) 0.93
4-Phenylcoumarins as HIV transcription inhibitors. Bioorg Med Chem Lett (2005) 0.92
Basal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression. Retrovirology (2007) 0.92
Understanding carbohydrate-carbohydrate interactions by means of glyconanotechnology. Glycoconj J (2004) 0.90
Glyconanoparticles polyvalent tools to study carbohydrate-based interactions. Adv Carbohydr Chem Biochem (2010) 0.89
Evaluation of the Abbott LCx quantitative assay for measurement of human immunodeficiency virus RNA in plasma. J Clin Microbiol (2002) 0.89
Galactofuranose-coated gold nanoparticles elicit a pro-inflammatory response in human monocyte-derived dendritic cells and are recognized by DC-SIGN. ACS Chem Biol (2013) 0.89
Live imaging of mouse endogenous neural progenitors migrating in response to an induced tumor. PLoS One (2012) 0.88
Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents. Bioorg Med Chem Lett (2010) 0.88
Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway. J Biol Chem (2004) 0.87
Mesuol, a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-kappaB pathway. Antiviral Res (2005) 0.87
Glyconanoparticles: multifunctional nanomaterials for biomedical applications. Nanomedicine (Lond) (2010) 0.87
Nanoparticles as nonviral gene delivery vectors. IEEE Trans Nanobioscience (2007) 0.86
Glyconanotechnology. Chem Soc Rev (2013) 0.85
Multivalent gold glycoclusters: high affinity molecular recognition by bacterial lectin PA-IL. Chemistry (2012) 0.85
68Ga-labeled gold glyconanoparticles for exploring blood-brain barrier permeability: preparation, biodistribution studies, and improved brain uptake via neuropeptide conjugation. J Am Chem Soc (2013) 0.85
Dual role of host cell factors in HIV-1 replication: restriction and enhancement of the viral cycle. AIDS Rev (2010) 0.84
Protein kinase Ctheta is a specific target for inhibition of the HIV type 1 replication in CD4+ T lymphocytes. J Biol Chem (2011) 0.84
Modulating glycosidase degradation and lectin recognition of gold glyconanoparticles. Carbohydr Res (2009) 0.84
Transcription elongation regulator 1 (TCERG1) regulates competent RNA polymerase II-mediated elongation of HIV-1 transcription and facilitates efficient viral replication. Retrovirology (2013) 0.83
The presence of HIV-1 Tat protein second exon delays fas protein-mediated apoptosis in CD4+ T lymphocytes: a potential mechanism for persistent viral production. J Biol Chem (2013) 0.83
Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot study. J Acquir Immune Defic Syndr (2004) 0.83
SDF-1/CXCL12 production by mature dendritic cells inhibits the propagation of X4-tropic HIV-1 isolates at the dendritic cell-T-cell infectious synapse. J Virol (2010) 0.83
A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity. Vaccine (2011) 0.82
Double addition of grignard reagents to N-glycosyl nitrones: a new tool for the construction of enantiopure azaheterocycles. Org Lett (2005) 0.82
Broadly neutralizing antibodies and their significance for HIV-1 vaccines. Curr HIV Res (2010) 0.82
Molecular phenotype of CXCL12beta 3'UTR G801A polymorphism (rs1801157) associated to HIV-1 disease progression. Curr HIV Res (2009) 0.81
Magnetic glyconanoparticles as a versatile platform for selective immunolabeling and imaging of cells. Bioconjug Chem (2011) 0.81
Fas activation of a proinflammatory program in rheumatoid synoviocytes and its regulation by FLIP and caspase 8 signaling. Arthritis Rheum (2006) 0.81
A solution NMR study of the interactions of oligomannosides and the anti-HIV-1 2G12 antibody reveals distinct binding modes for branched ligands. Chemistry (2011) 0.81
Specific labelling of cell populations in blood with targeted immuno-fluorescent/magnetic glyconanoparticles. Biomaterials (2011) 0.81
Paramagnetic Gd-based gold glyconanoparticles as probes for MRI: tuning relaxivities with sugars. Chem Commun (Camb) (2009) 0.81
Genetic analysis of the long terminal repeat (LTR) promoter region in HIV-1-infected individuals with different rates of disease progression. Virus Genes (2006) 0.80
Guatemalan plants extracts as virucides against HIV-1 infection. Phytomedicine (2008) 0.80
Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants. Antiviral Res (2010) 0.80
Characterization of the wheat germ agglutinin binding to self-assembled monolayers of neoglycoconjugates by AFM and SPR. Glycobiology (2009) 0.80
A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence. Carcinogenesis (2009) 0.80
Gold manno-glyconanoparticles for intervening in HIV gp120 carbohydrate-mediated processes. Methods Enzymol (2012) 0.80
3-Phenylcoumarins as inhibitors of HIV-1 replication. Molecules (2012) 0.80
Application of proteomics technology for analyzing the interactions between host cells and intracellular infectious agents. Proteomics (2008) 0.80
A quantitative study of the intracellular dynamics of fluorescently labelled glyco-gold nanoparticles via fluorescence correlation spectroscopy. Small (2014) 0.79
Association between stromal cell-derived factor 1 chemokine gene variant and radiographic progression of rheumatoid arthritis. Arthritis Rheum (2005) 0.79
Effective targeting of DC-SIGN by α-fucosylamide functionalized gold nanoparticles. Bioconjug Chem (2014) 0.78
Structure-based design of an RNA-binding p-terphenylene scaffold that inhibits HIV-1 Rev protein function. Angew Chem Int Ed Engl (2013) 0.78
Dissecting the carbohydrate specificity of the anti-HIV-1 2G12 antibody by single-molecule force spectroscopy. Langmuir (2012) 0.78
High sensitive detection of carbohydrate binding proteins in an ELISA-solid phase assay based on multivalent glyconanoparticles. PLoS One (2013) 0.78
Mechanisms of RNA interference in the HIV-1-host cell interplay. AIDS Rev (2011) 0.78
NMR studies on the conformation of oligomannosides and their interaction with banana lectin. Glycoconj J (2007) 0.78
A strategy utilizing a recyclable macrocycle transporter for the efficient synthesis of a triazolium-based [2]rotaxane. Angew Chem Int Ed Engl (2014) 0.78
Anti-HIV activity of stilbene-related heterocyclic compounds. Bioorg Med Chem Lett (2006) 0.78
Uptake and intracellular fate of fluorescent-magnetic glyco-nanoparticles. Adv Healthc Mater (2012) 0.77
Cell response to magnetic glyconanoparticles: does the carbohydrate matter? IEEE Trans Nanobioscience (2007) 0.77
Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy. Expert Opin Drug Metab Toxicol (2011) 0.77